Assessment of causes of death in a prostate cancer screening trial
Open Access
- 16 November 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 122 (2), 413-417
- https://doi.org/10.1002/ijc.23126
Abstract
Accurate assessment of the causes of death is crucial for a conclusive evaluation of the ongoing prostate cancer screening trials. Here, we report the validity of the official causes of death as compared with an independent expert review in the Finnish prostate cancer screening trial. Because nearly 80,000 men were involved, death-cause evaluation was restricted to men diagnosed for prostate cancer. Medical charts were retrieved and the cause of death was assigned by an expert review panel for all deaths among men with prostate cancer during the study period, 1996–2003. The panel decision was compared with both death certificates and the official causes of death as assigned by Statistics Finland. Of a total of 315 deaths, the review panel attributed 127 (41%) to prostate cancer and 184 (59%) to other causes, the corresponding figures in death certificates being 124 (40%) and 187 (60%). Four cases were excluded because of insufficient information. The death-certificate data were in agreement with the panel's assessment in 305 out of 311 cases (overall agreement 97.7%, κ = 0.95). The overall agreement between the official causes of death and the panel's decision was 97.4% (304/311, κ = 0.95). The sensitivity of the certificates in identifying prostate cancer deaths was 96.1% (panel as golden standard). Correspondingly, specificity was 98.9%. The official causes of death thus provide an accurate means for evaluating disease-specific mortality in a large population-based prostate-cancer screening trial in Finland.Funding Information
- Academy of Finland
- Cancer Society of Finland
This publication has 25 references indexed in Scilit:
- Value of an Endpoints Committee versus the use of nosologists for validating cause of deathContemporary Clinical Trials, 2006
- Trends in prostate cancer mortality among black men and white men in the United StatesCancer, 2003
- Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trialInternational Journal of Cancer, 2001
- Determining Cause of Death in Prostate Cancer: Are Death Certificates Valid?JNCI Journal of the National Cancer Institute, 2001
- A COMPARISON OF CAUSE OF DEATH DETERMINATION IN MEN PREVIOUSLY DIAGNOSED WITH PROSTATE CANCER WHO DIED IN 1985 OR 1995Journal of Urology, 2000
- Is the apparent rise in cancer mortality in the elderly real? analysis of changes in certification and coding of cause of death in England and Wales, 1970–1990International Journal of Cancer, 1995
- Determination of Cause of Death Among Breast Cancer Cases in the Swedish Randomized Mammography Screening Trials: A comparison between official statistics and validation by an endpoint committeeActa Oncologica, 1995
- Data Quality and Quality Control of a Population-Based Cancer Registry: Experience in FinlandActa Oncologica, 1994
- The Autopsy as a Measure of Accuracy of the Death CertificateThe New England Journal of Medicine, 1985
- Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit.Psychological Bulletin, 1968